Work

Integrated safety analysis of venetoclax monotherapy in chronic lymphocytic leukemia (CLL).

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.15_suppl.7528

Authors: Matthew Steven Davids, John F. Gerecitano, Jalaja Potluri, Elisa Cerri, Su Young Kim, Mark Steinberg, Maria Verdugo, Todd A. Busman, Sari H. Enschede, Mehrdad Mobasher, Andrea Best, Monali B Desai, William G. Wierda

Institutions: Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, Memorial Sloan Kettering Cancer Center, AbbVie (United States), Genentech, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2761324813

Cites:

Cited by: 4

Related to: 10